Collectively, our results demonstrated that RSL1D1 overexpression promoted the growth and metastasis of CRC cells in vitro and in vivo, strongly indicating that RSL1D1 functions as a tumor promoter in CRC. This evidence concerns the gene RSL1D1 and colorectal carcinoma.